For more than 25 years, Curtis Capeling has focused on assisting clients in the strategic protection and commercialization of their intellectual property assets and rights. He advises start-up and emerging private companies, as well as public companies in a wide variety of industries, including technology, healthcare, consumer products, media and professional services. His practice includes:
Prior to joining Bass, Berry & Sims, Curtis was a shareholder at Harwell Howard Hyne Gabbert & Manner, P.C.
International Technology Law Association
American Intellectual Property Law Association
American Bar Association
Nashville Bar Association
American Health Law Association (AHLA)
Lead Counsel to POINT Biopharma Inc. in connection with its proposed SPAC business combination with Therapeutics Acquisition Corp. d/b/a Research Alliance Corp. I (Nasdaq: RACA), a special purpose acquisition company, sponsored by RA Capital Management. Upon closing, the combined company will be named POINT Biopharma Global Inc. and is expected to be listed on Nasdaq under the ticker symbol “PNT”.
Representation of Heritage Global Inc. (Nasdaq: HGBL), an asset services company specializing in financial and industrial assets, in its public offering of 5,462,500 shares of common stock with proceeds of $9,559,375. The underwriters included Lake Street Capital Markets, LLC and Colliers Securities, LLC.
Representation of My Retirement Account Services, LLC, a platform for the custody of cryptocurrencies in IRAs and other retirement accounts, in its merger with Kingdom Services Holdings, LLC
Representation of Element Solutions, Inc. (NYSE: ESI), specialty chemicals production corporation, in its acquisition of DMP Corporation, a designer and manufacturer of industrial wastewater treatment systems and chemicals
Representation of TailTrax, LLC, a veterinarian and pet health platform, in its sale to PetPartners, Inc., a pet insurance provider
Nashville Post “101 Top Lawyer” (2011)